Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155
Yang Qu, Zhengming Wang, Haohan Zhou, Mingyang Kang, Rongpeng Dong, Jianwu Zhao Department of Orthopedics, The Second Hospital of Jilin University, Changchun, People’s Republic of China Abstract: Degenerative lumbar disease (DLD) is a significant issue for public health. Posterior lumbar...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4d30bd9c9a0a43b89496216a52ccb512 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4d30bd9c9a0a43b89496216a52ccb512 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4d30bd9c9a0a43b89496216a52ccb5122021-12-02T01:46:44ZOligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-1551178-2013https://doaj.org/article/4d30bd9c9a0a43b89496216a52ccb5122017-11-01T00:00:00Zhttps://www.dovepress.com/oligosaccharide-nanomedicine-of-alginate-sodium-improves-therapeutic-r-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yang Qu, Zhengming Wang, Haohan Zhou, Mingyang Kang, Rongpeng Dong, Jianwu Zhao Department of Orthopedics, The Second Hospital of Jilin University, Changchun, People’s Republic of China Abstract: Degenerative lumbar disease (DLD) is a significant issue for public health. Posterior lumbar intervertebral fusion with cages (PLIFC) has high-level fusion rate and realignment on DLD. However, there are some complications following the surgery. Alginate oligosaccharides (AOS) have antioxidant and anti-inflammatory activities and may be suitable for infection therapy. MiR-155 is a biomarker associated with inflammatory and oxidative stress. AOS may promote PLIFC therapy by regulating miR-155. Pluronic nanoparticles and oligosaccharide nanomedicine of alginate sodium (ONAS) were prepared with ampicillin at size <200 nm. Ninety-six DLD osteoporosis patients received PLIFC and were evenly assigned into ONAS group (OG, oral administration of 100 mg ONAS daily) and control group (PG, 100 mg pluronic nanoparticles). Serum miR-155 level was measured by real-time quantitative PCR. The levels of superoxide dismutase (SOD), glutathione (GSH), aspartate aminotransaminase (AST), alanine aminotransferase (ALT), interleukin-1β (IL-1β), and interleukin-1 receptor antagonist (IL-1ra) were measured. Weighted mean difference (WMD), relative risk (RR), complications, surgery infection rate, fusion rate, and Japanese Orthopaedic Association (JOA) scores were used to evaluate therapeutic efficacy. After 1-month therapy, infection rates and side effects were lower in OG than those in PG (RR =0.64, 95% confidence interval [CI] [0.48, 0.84], P=0.001). The fusion rates were higher in OG than in PG (WMD =21.96, 95% CI [–0.24, 37.62], P=0.021). The JOA scores were higher in OG than in PG (RR =0.52, 95% CI [0.33, 0.84], P=0.007), and no significant difference was found for the visual analog scale and Oswestry Disability Index. Serum levels of miR-155, ALT, AST, and IL-1β were lower while SOD, GSH, and IL-1ra were higher in OG than in PG. MiR-155 mimic increased the levels of ALT, AST, and IL-1β and reduced the levels of SOD, GSH, and IL-1ra. In contrast, miR-155 inhibitor had reverse results. Therefore, ONAS has better improvement in complications and therapeutic effects on DLD by regulating serum miR-155. Keywords: alginate oligosaccharide, antioxidant, anti-inflammatory, fusion rate, infection rate, Japanese Orthopaedic Association, Oswestry Disability IndexQu YWang ZZhou HKang MDong RZhao JDove Medical Pressarticlecageposterior lumbar interbody fusionfusion rateJapanese Orthopaedic AssociationOswestry Disability IndexOligosaccharide nanomedicine of alginate sodiumserum miR-155antioxidantanti-inflammatoryMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 8459-8469 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
cage posterior lumbar interbody fusion fusion rate Japanese Orthopaedic Association Oswestry Disability Index Oligosaccharide nanomedicine of alginate sodium serum miR-155 antioxidant anti-inflammatory Medicine (General) R5-920 |
| spellingShingle |
cage posterior lumbar interbody fusion fusion rate Japanese Orthopaedic Association Oswestry Disability Index Oligosaccharide nanomedicine of alginate sodium serum miR-155 antioxidant anti-inflammatory Medicine (General) R5-920 Qu Y Wang Z Zhou H Kang M Dong R Zhao J Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| description |
Yang Qu, Zhengming Wang, Haohan Zhou, Mingyang Kang, Rongpeng Dong, Jianwu Zhao Department of Orthopedics, The Second Hospital of Jilin University, Changchun, People’s Republic of China Abstract: Degenerative lumbar disease (DLD) is a significant issue for public health. Posterior lumbar intervertebral fusion with cages (PLIFC) has high-level fusion rate and realignment on DLD. However, there are some complications following the surgery. Alginate oligosaccharides (AOS) have antioxidant and anti-inflammatory activities and may be suitable for infection therapy. MiR-155 is a biomarker associated with inflammatory and oxidative stress. AOS may promote PLIFC therapy by regulating miR-155. Pluronic nanoparticles and oligosaccharide nanomedicine of alginate sodium (ONAS) were prepared with ampicillin at size <200 nm. Ninety-six DLD osteoporosis patients received PLIFC and were evenly assigned into ONAS group (OG, oral administration of 100 mg ONAS daily) and control group (PG, 100 mg pluronic nanoparticles). Serum miR-155 level was measured by real-time quantitative PCR. The levels of superoxide dismutase (SOD), glutathione (GSH), aspartate aminotransaminase (AST), alanine aminotransferase (ALT), interleukin-1β (IL-1β), and interleukin-1 receptor antagonist (IL-1ra) were measured. Weighted mean difference (WMD), relative risk (RR), complications, surgery infection rate, fusion rate, and Japanese Orthopaedic Association (JOA) scores were used to evaluate therapeutic efficacy. After 1-month therapy, infection rates and side effects were lower in OG than those in PG (RR =0.64, 95% confidence interval [CI] [0.48, 0.84], P=0.001). The fusion rates were higher in OG than in PG (WMD =21.96, 95% CI [–0.24, 37.62], P=0.021). The JOA scores were higher in OG than in PG (RR =0.52, 95% CI [0.33, 0.84], P=0.007), and no significant difference was found for the visual analog scale and Oswestry Disability Index. Serum levels of miR-155, ALT, AST, and IL-1β were lower while SOD, GSH, and IL-1ra were higher in OG than in PG. MiR-155 mimic increased the levels of ALT, AST, and IL-1β and reduced the levels of SOD, GSH, and IL-1ra. In contrast, miR-155 inhibitor had reverse results. Therefore, ONAS has better improvement in complications and therapeutic effects on DLD by regulating serum miR-155. Keywords: alginate oligosaccharide, antioxidant, anti-inflammatory, fusion rate, infection rate, Japanese Orthopaedic Association, Oswestry Disability Index |
| format |
article |
| author |
Qu Y Wang Z Zhou H Kang M Dong R Zhao J |
| author_facet |
Qu Y Wang Z Zhou H Kang M Dong R Zhao J |
| author_sort |
Qu Y |
| title |
Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| title_short |
Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| title_full |
Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| title_fullStr |
Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| title_full_unstemmed |
Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155 |
| title_sort |
oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum mir-155 |
| publisher |
Dove Medical Press |
| publishDate |
2017 |
| url |
https://doaj.org/article/4d30bd9c9a0a43b89496216a52ccb512 |
| work_keys_str_mv |
AT quy oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 AT wangz oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 AT zhouh oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 AT kangm oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 AT dongr oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 AT zhaoj oligosaccharidenanomedicineofalginatesodiumimprovestherapeuticresultsofposteriorlumbarinterbodyfusionwithcagesfordegenerativelumbardiseaseinosteoporosispatientsbydownregulatingserummir155 |
| _version_ |
1718402894466646016 |